Anorexia nervosa (AN) is a serious disorder affecting adolescents and young adults, and decreases quality of life over long period. 1 Successful weight restoration is an important prognostic factor for disease outcome; 1 however, the underlying mechanism of refeeding-resistance (RR), a core psychopathology relevant to 'ambivalent' eating behaviors, remains unclear in this disorder. [2] [3] [4] High mobility group box 1 (HMGB1), a ubiquitous DNA binding protein, 5 plays various extracellular roles as a proinflammatory cytokine, an immune adjuvant, a repair factor for injured tissues and a mediator of anorexia. [6] [7] [8] We therefore investigated whether serum HMGB1 levels are associated with acute conditions, refeeding progress or RR in patients with AN.
Eleven During the first hospital week (observation (OB) period), no therapeutic intervention was applied. 2, 3, 9 On day 7, baseline assessment was made, including body weight (BW), mean values of daily energy intake (EI) and proinflammatory cytokines using high-sensitivity assay such as tumor necrosis factor (TNF)-a, interleukin (IL)-1b (R&D Systems, Minneapolis, MN, USA for both) and IL-6 (Fujirebio Inc., Tokyo, Japan). Serum HMGB1 assay via ELISA was performed (Shino-test Corporation, Kanagawa, Japan). 8 Thereafter, all patients started the same 12-week treatment program consisting of nutritional rehabilitation and cognitive behavior therapy. 2, 3, 9 Total daily EI started at 1000 kcal and increased by 200 kcal/ week. After completely eating served meals for 1 week, patients were allowed to start the next EI stage. After 1600 kcal/day, weight gain X0.5 kg/week was required. 2, 3, 9 If the patient failed for two consecutive weeks owing to fear of obesity (RR period), a second assessment was performed on day 14 of that period.
Changes between baseline and the second assessment were determined for serum HMGB1 (delta HMGB1), daily EI (delta EI) and BW (delta BW). We also recorded BW changes during the week before the second assessment (delta BW-RR). Between-group comparisons were performed by Student's t-test or one-factor analysis of variance followed by Bonferroni correction using Stat View 5.0.1 (SAS Institute Inc., Cary, NC, USA). Results were expressed as mean7s.d. Significance was set at P < 0.05.
All patients experienced the RR period (mean time to this period: 9.772.2 weeks). AN patients during the OB and RR periods showed significantly lower BMI (13.671.8 and 14.471.8 kg/m 2 , respectively) and FBS values (4.170.3 and 4.370.2 mmol/l, respectively) than controls (P < 0.0001 for both). AN patients during the RR period differed from those during the OB period in daily EI (18277155 vs 11637233 kcal, P < 0.0001) and serum AST (23.875.2 vs 53.3745.6 IU/l, P < 0.05). No significant group effects were detected in cytokines. AN patients during the RR period showed significantly higher HMGB1 values than those during the OB period or controls (P = 0.002; Figure 1 ). Delta HMGB1 was positively correlated with delta EI (r = 0.73; P = 0.01) and delta BW (r = 0.80; P = 0.003) and negatively correlated with delta BW-RR (r = À0.61; P = 0.04).
This study suggests that serum HMGB1 levels may be related to not only refeeding progress (that is, delta BW and delta EI) but also RR (that is, delta BW-RR). Together with these variables, serum HMGB1 levels may form an RR loop in AN patients.
Elucidation of the underlying mechanism of HMGB1 release remains limited. HMGB1 is released passively by necrotic or damaged cells and actively by monocyte/macrophages via proinflammatory cytokines. [5] [6] [7] Normalization of malnutritional abnormalities (for example, serum AST) during the RR period may not support the earlier pathway, and our cytokine results may not support the latter pathway. However, recent studies on AN have yielded inconsistent results, with either increased or unchanged serum levels of IL-1b, IL-6 and TNF-a; 10 thus, further studies with a larger sample size are needed to investigate the relationship between serum HMGB1 and cytokine levels in anorexics. Delta HMGB1 values related to refeeding progress suggests that nutritional factors may play an important role in HMGB1 release in anorexics.
The small sample size and lack of examination of central HMGB1 activities may limit this study. HMGB1-induced anorexia is mainly mediated by intracerebral effects; 7 thus, further studies on these Several studies have indicated that melatonin, a pineal gland hormone synthesized from serotonin, 
